Wooree Bio Co.,Ltd (KOSDAQ:082850)
South Korea
· Delayed Price · Currency is KRW 2,370.00
-20.00 (-0.84%)
At close: Jun 19, 2025, 3:30 PM KST
Wooree Bio Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,243,324 | 1,237,198 | 1,263,944 | 1,355,056 | 1,543,312 | 1,623,383 | Upgrade
|
| Other Revenue | 0 | - | -0 | - | - | 0 | Upgrade
|
| Revenue | 1,243,324 | 1,237,198 | 1,263,944 | 1,355,056 | 1,543,312 | 1,623,383 | Upgrade
|
| Revenue Growth (YoY) | -3.50% | -2.12% | -6.72% | -12.20% | -4.93% | -2.94% | Upgrade
|
| Cost of Revenue | 1,127,722 | 1,119,187 | 1,148,606 | 1,241,417 | 1,427,899 | 1,523,846 | Upgrade
|
| Gross Profit | 115,601 | 118,012 | 115,337 | 113,639 | 115,412 | 99,537 | Upgrade
|
| Selling, General & Admin | 83,999 | 84,804 | 74,363 | 65,396 | 57,472 | 47,617 | Upgrade
|
| Research & Development | 12,227 | 11,439 | 8,398 | 7,019 | 7,382 | 6,631 | Upgrade
|
| Other Operating Expenses | 1,547 | 1,548 | 1,350 | 1,884 | 1,274 | 1,376 | Upgrade
|
| Operating Expenses | 102,571 | 102,812 | 89,355 | 79,398 | 72,995 | 62,095 | Upgrade
|
| Operating Income | 13,030 | 15,200 | 25,982 | 34,241 | 42,417 | 37,442 | Upgrade
|
| Interest Expense | -6,035 | -5,402 | -6,052 | -4,948 | -4,438 | -6,468 | Upgrade
|
| Interest & Investment Income | 3,979 | 4,365 | 3,834 | 1,632 | 427.15 | 320.28 | Upgrade
|
| Earnings From Equity Investments | -155.5 | -79.77 | -190.83 | -123.76 | -184.23 | 13.08 | Upgrade
|
| Currency Exchange Gain (Loss) | 6,275 | 8,637 | -1,908 | -116.95 | 4,510 | -2,077 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,885 | 3,829 | 250.77 | 1,224 | 2,566 | 3,930 | Upgrade
|
| EBT Excluding Unusual Items | 20,979 | 26,548 | 21,917 | 31,909 | 45,298 | 33,161 | Upgrade
|
| Gain (Loss) on Sale of Investments | 27.87 | - | - | - | 188.71 | -1,865 | Upgrade
|
| Gain (Loss) on Sale of Assets | 336.87 | 317.61 | -187.34 | 117.01 | -206.37 | -9,019 | Upgrade
|
| Asset Writedown | -2,327 | -2,327 | - | - | - | -52.45 | Upgrade
|
| Pretax Income | 19,017 | 24,539 | 21,729 | 32,026 | 45,281 | 22,224 | Upgrade
|
| Income Tax Expense | 15,153 | 16,312 | 2,783 | 6,900 | 1,239 | 5,241 | Upgrade
|
| Earnings From Continuing Operations | 3,864 | 8,227 | 18,946 | 25,126 | 44,041 | 16,983 | Upgrade
|
| Net Income to Company | 3,864 | 8,227 | 18,946 | 25,126 | 44,041 | 16,983 | Upgrade
|
| Minority Interest in Earnings | -1,852 | -3,483 | -3,365 | -3,304 | -10,886 | -141.65 | Upgrade
|
| Net Income | 2,012 | 4,743 | 15,581 | 21,822 | 33,156 | 16,841 | Upgrade
|
| Net Income to Common | 2,012 | 4,743 | 15,581 | 21,822 | 33,156 | 16,841 | Upgrade
|
| Net Income Growth | -87.63% | -69.56% | -28.60% | -34.18% | 96.87% | 271.64% | Upgrade
|
| Shares Outstanding (Basic) | 47 | 47 | 47 | 46 | 44 | 44 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 47 | 47 | 46 | 48 | 45 | Upgrade
|
| Shares Change (YoY) | 0.20% | 0.13% | 1.95% | -2.87% | 5.70% | - | Upgrade
|
| EPS (Basic) | 42.62 | 100.50 | 330.98 | 469.36 | 750.13 | 385.66 | Upgrade
|
| EPS (Diluted) | 42.02 | 100.00 | 329.00 | 469.00 | 702.06 | 376.03 | Upgrade
|
| EPS Growth | -87.77% | -69.60% | -29.85% | -33.20% | 86.70% | 253.57% | Upgrade
|
| Free Cash Flow | -91,438 | -45,711 | 16,018 | 30,085 | 38,588 | 52,167 | Upgrade
|
| Free Cash Flow Per Share | -1926.79 | -963.15 | 337.94 | 647.10 | 806.13 | 1151.92 | Upgrade
|
| Gross Margin | 9.30% | 9.54% | 9.13% | 8.39% | 7.48% | 6.13% | Upgrade
|
| Operating Margin | 1.05% | 1.23% | 2.06% | 2.53% | 2.75% | 2.31% | Upgrade
|
| Profit Margin | 0.16% | 0.38% | 1.23% | 1.61% | 2.15% | 1.04% | Upgrade
|
| Free Cash Flow Margin | -7.35% | -3.69% | 1.27% | 2.22% | 2.50% | 3.21% | Upgrade
|
| EBITDA | 40,030 | 42,731 | 57,832 | 70,435 | 77,974 | 76,287 | Upgrade
|
| EBITDA Margin | 3.22% | 3.45% | 4.58% | 5.20% | 5.05% | 4.70% | Upgrade
|
| D&A For EBITDA | 27,000 | 27,531 | 31,850 | 36,194 | 35,557 | 38,845 | Upgrade
|
| EBIT | 13,030 | 15,200 | 25,982 | 34,241 | 42,417 | 37,442 | Upgrade
|
| EBIT Margin | 1.05% | 1.23% | 2.06% | 2.53% | 2.75% | 2.31% | Upgrade
|
| Effective Tax Rate | 79.68% | 66.47% | 12.81% | 21.54% | 2.74% | 23.58% | Upgrade
|
| Advertising Expenses | - | 8,170 | 9,177 | 8,633 | 3,642 | 246.06 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.